Home › Funds › Vestal Point Capital, LP › ANIX
Vestal Point Capital, LP position in ANIX
ANIXA BIOSCIENCES INC · Health Care
Vestal Point Capital, LP reported holding 263,105 shares of ANIX (ANIXA BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$8.4M, representing 0.22% of its reported portfolio and ranking #41 among its reported holdings. Vestal Point Capital, LP first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Vestal Point Capital, LP's ANIX position evolved
Vestal Point Capital, LP first disclosed a stake in ANIX in Q3 2026 at 263,105 shares (US$8.4M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 263.11K | $8.42M | New |
About ANIX and 13F data
ANIX (ANIXA BIOSCIENCES INC) is a Health Care company. 55 other funds we track also report a position in ANIX — the largest reported positions include Fairmount Funds Management LLC (US$291.3M), TCG Crossover Management, LLC (US$145.6M), Venrock Adviser, LLC (US$145.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANIX
- Fairmount Funds Management LLC 9.10M sh · $291.32M · Q3 2026
- TCG Crossover Management, LLC 4.55M sh · $145.59M · Q3 2026
- Venrock Adviser, LLC 4.55M sh · $145.59M · Q3 2026
- FCPM III SERVICES B.V. 2.19M sh · $70.15M · Q3 2026
- Sanofi 1.99M sh · $63.81M · Q3 2026
- Foresite Capital Management VI LLC 1.43M sh · $45.81M · Q3 2026
- RA CAPITAL MANAGEMENT, L.P. 892.74K sh · $28.57M · Q3 2026
- Commodore Capital LP 877.02K sh · $28.06M · Q3 2026
- Vivo Capital, LLC 877.02K sh · $28.06M · Q3 2026
- SR ONE CAPITAL MANAGEMENT, LP 613.91K sh · $19.65M · Q3 2026
- Paradigm Biocapital Advisors LP 613.91K sh · $19.65M · Q3 2026
- Remedium Capital Partners, LLC 518.50K sh · $16.59M · Q3 2026
More on Vestal Point Capital, LP
FAQ
How long has Vestal Point Capital, LP held ANIX?
Vestal Point Capital, LP has disclosed ANIX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Vestal Point Capital, LP's current position in ANIX?
As of Q3 2026, Vestal Point Capital, LP holds 263.11K shares of ANIX (ANIXA BIOSCIENCES INC), valued at $8.42M, representing 0.22% of its reported portfolio and ranking #41.
Has Vestal Point Capital, LP been buying or selling ANIX?
In the latest 13F filing (Q3 2026), Vestal Point Capital, LP newly opened its position in ANIX.
Which other funds hold ANIX?
Other major institutional holders of ANIX include Fairmount Funds Management LLC, TCG Crossover Management, LLC, Venrock Adviser, LLC, among 55 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.